Action VCXB 10X CAPITAL VENTURE ACQUISITION CORP. III
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues 10X Capital Venture Acquisition Corp. III

Actions

VCXB

KYG870771063

Marché Fermé - Nyse
Autres places de cotation
 22:15:00 25/06/2024 		Varia. 5j. Varia. 1 janv.
11 USD 0,00% Graphique intraday de 10X Capital Venture Acquisition Corp. III 0,00% +2,42%
21/06 Addimmune a annulé l'acquisition de 10X Capital Venture Acquisition Corp. III (NYSEAM:VCXB) auprès d'un groupe d'actionnaires dans le cadre d'une opération de fusion inversée. CI
09/01 10X Capital Venture Acquisition Corp. III annonce des changements au niveau de la direction générale CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Addimmune cancelled the acquisition of 10X Capital Venture Acquisition Corp. III from a group of shareholders in a reverse merger transaction.
10X Capital Venture Acquisition Corp. III Gets Non-Compliance Notice From NYSE American
10X Capital Venture Acquisition III : Material Event - Form 8-K
10X Capital Venture Acquisition Receives NYSE Non-Compliance Notice for Low Shareholder Count
10X Capital Venture Acquisition Corp. III Announces Chief Executive Officer Changes
10X Capital Venture Acquisition Receives Non-Compliance Notice From New York Stock Exchange
10X Capital Venture Acquisition Corp. III Receives NYSE Notice Regarding Late Form 10-Q Filing
10X Capital Venture Acquisition Corp. III Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
10X Capital Venture Acquisition Corp. III announced that it expects to receive $5.9 million in funding
10X Capital Venture Acquisition to Move Listing of Securities to NYSE American
10X Capital Venture Acquisition Corp. III Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
10X Capital Venture Acquisition Corp. III Agrees to Business Combination With American Gene Technologies
Addimmune entered into a merger agreement for a business combination to acquire 10X Capital Venture Acquisition Corp. III from a group of shareholders in a reverse merger transaction.
10X Capital Venture Acquisition Corp. III Reports Earnings Results for the First Quarter Ended March 31, 2023
10X Capital Venture Acquisition III : Non-Reliance on Previously Issued Financial Report - Form 8-K
10X Capital Venture Acquisition Corp. III Reports Earnings Results for the Full Year Ended December 31, 2022
10X Capital Venture Acquisition Corp. III Auditor Raises 'Going Concern' Doubt
Sparks Energy, Inc. cancelled the acquisition of 10X Capital Venture Acquisition Corp. III from a group of shareholders in a reverse merger transaction.
10X Capital Venture Acquisition III : In the court of chancery of the state of delaware - Form 8-K
10X Capital Venture Acquisition III : Merger Agreement - Form 8-K
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VCXB
  4. Actualités 10X Capital Venture Acquisition Corp. III
  5. Autres langues